Tezosentan

Tezosentan
Clinical data
ATC code	none;
Identifiers
	IUPAC name N-[6-(2-Hydroxyethoxy)-5-(2-methoxyphenoxy)-2-[2-(2H-tetrazol-5-yl)pyridin-4-yl]pyrimidin-4-yl]-5-propan-2-ylpyridine-2-sulfonamide;
CAS Number	180384-57-0 ;
PubChem CID	151174;
ChemSpider	133242 ;
UNII	64J9J55263;
ChEMBL	ChEMBL61780 ;
CompTox Dashboard (EPA)	DTXSID20170956 ;
Chemical and physical data
Formula	C27H27N9O6S
Molar mass	605.63 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=S(=O)(c1ncc(cc1)C(C)C)Nc3nc(nc(OCCO)c3Oc2ccccc2OC)c5ccnc(c4n[nH]nn4)c5;
	InChI InChI=1S/C27H27N9O6S/c1-16(2)18-8-9-22(29-15-18)43(38,39)34-26-23(42-21-7-5-4-6-20(21)40-3)27(41-13-12-37)31-24(30-26)17-10-11-28-19(14-17)25-32-35-36-33-25/h4-11,14-16,37H,12-13H2,1-3H3,(H,30,31,34)(H,32,33,35,36) ; Key:TUYWTLTWNJOZNY-UHFFFAOYSA-N ;
	(verify)

Tezosentan is a non-selective ET_A and ET_B receptor antagonist.^[1] It acts as a vasodilator and was designed by Actelion as a therapy for patients with acute heart failure. However, studies showed that tezosentan did not improve dyspnea or reduce the risk of fatal or nonfatal cardiovascular events.^[2]

References

^ Urbanowicz W, Sogni P, Moreau R, Tazi KA, Barriere E, Poirel O, et al. (December 2004). "Tezosentan, an endothelin receptor antagonist, limits liver injury in endotoxin challenged cirrhotic rats". Gut. 53 (12). BMJ Publishing Group Ltd & British Society of Gastroenterology: 1844–9. doi:10.1136/gut.2003.036517. PMC 1774327. PMID 15542526.
^ "Tezosentan does not appear to improve symptoms for patients with acute heart failure". Medical Studies/Trials. news-medical.net. 7 Nov 2007. Retrieved 2007-11-24.

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.

[Urbanowicz-1] Urbanowicz W, Sogni P, Moreau R, Tazi KA, Barriere E, Poirel O, et al. (December 2004). "Tezosentan, an endothelin receptor antagonist, limits liver injury in endotoxin challenged cirrhotic rats". Gut. 53 (12). BMJ Publishing Group Ltd & British Society of Gastroenterology: 1844–9. doi:10.1136/gut.2003.036517. PMC 1774327. PMID 15542526.

[news-med-2] "Tezosentan does not appear to improve symptoms for patients with acute heart failure". Medical Studies/Trials. news-medical.net. 7 Nov 2007. Retrieved 2007-11-24.

[1]

[2]

Clinical data


ATC code	none
Identifiers
IUPAC name N-[6-(2-Hydroxyethoxy)-5-(2-methoxyphenoxy)-2-[2-(2H-tetrazol-5-yl)pyridin-4-yl]pyrimidin-4-yl]-5-propan-2-ylpyridine-2-sulfonamide
CAS Number	180384-57-0^Y
PubChem CID	151174
ChemSpider	133242^Y
UNII	64J9J55263
ChEMBL	ChEMBL61780^Y
CompTox Dashboard (EPA)	DTXSID20170956
Chemical and physical data
Formula	C₂₇H₂₇N₉O₆S
Molar mass	605.63 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES O=S(=O)(c1ncc(cc1)C(C)C)Nc3nc(nc(OCCO)c3Oc2ccccc2OC)c5ccnc(c4n[nH]nn4)c5
InChI InChI=1S/C27H27N9O6S/c1-16(2)18-8-9-22(29-15-18)43(38,39)34-26-23(42-21-7-5-4-6-20(21)40-3)27(41-13-12-37)31-24(30-26)17-10-11-28-19(14-17)25-32-35-36-33-25/h4-11,14-16,37H,12-13H2,1-3H3,(H,30,31,34)(H,32,33,35,36)^Y Key:TUYWTLTWNJOZNY-UHFFFAOYSA-N^Y
(verify)

Tezosentan

References

zproxy.org